GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


HETEROGENEITY OF TREATMENT EFFECT IN CLINICAL TRIALS


OBJECTIVES

The objective of this course is to give you guidance on how to differentiate credible from less credible subgroup claims in clinical trials. For this purpose, some established criteria to assess the validity of subgroup analyses will be reviewed.

This course also aims to give you an overview of the different scenarios that the European Medicine Agency considers in its guideline for subgroup assessment in late-stage or confirmatory clinical trials. For each scenario some examples will be reviewed.

Absolute answer, Patient, Cluster, Benefit-risk, Profile

 

LEARNING OUTCOMES

At the end of this course, you will be familiar with the concepts related to the heterogeneity of treatment effect and how to interpret the results according to the method used to cope with.

 

120 minutes
Online based learning
English language
Certificate of Achievement
200 €
REGISTER NOW

AUTHORS

avatar

Josep Maria Castel

Universitat Autònoma de Barcelona

avatar

Dr. Antònia Agustí

Universitat Autònoma de Barcelona


avatar

Dr. Xavier Vidal

Universitat Autònoma de Barcelona

avatar

Dr. Montse Bosche

Universitat Autònoma de Barcelona




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners